News
Researchers at St. Louis University followed 110 men with obesity, many with type 2 diabetes, who were being treated with GLP ...
In a survey of 2,000 single adults ages 18 to 91 conducted by Indiana University, among those taking GLP-1 drugs to lose ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
The reality TV star and certified obesity physician Dr. Holly Lofton plan to use the show to further educate GLP-1 users on ...
GLP-1s double as not only a weight loss drug but also a dating confidence booster. Fifty-nine percent of surveyed GLP-1 users ...
More than 40% of American's are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic ...
Explore more
Danone company Kate Farms tapped its medical nutrition expertise to craft a high-protein shake for everyday wellness. Here’s ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
Real success is about taking control, gaining confidence, and achieving the energy to live life to the full, not simply shedding kilos.
23h
MedPage Today on MSNGLP-1 Drugs Linked to GERD; Best Upfront Approach for H. Pylori? AI in ColonoscopyA similar study in Gastro Hep Advances found higher odds of GERD and gastroparesis among patients with type 2 diabetes taking GLP-1 agonists versus SGLT-2 inhibitors, but lower odds of acute ...
Customers can now access treatments far beyond basic hair and nail care, from wrinkle-smoothing Botox and fillers to permanent laser hair removal and even weight management through GLP-1 medications.
11h
HealthDay on MSNGLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD ComplicationsFor patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an incr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results